The thyroid gland plays a vital role in regulating key body functions, but when it’s dysregulated, the typical treatment involves synthetic T4 and T3. A small number of patients still use desiccated thyroid extract derived from animals, but the FDA plans to phase it out due to safety and dosing concerns. Our experts explain why patients are still using DTE and why they’re being transitioned to other options.
Guest Information:
- Dr. Anne Cappola, professor of medicine, Perelman School of Medicine University of Pennsylvania
- Tenille Davis, Chief Advocacy Officer, Alliance for Pharmacy Compounding
Links for more info:
The post Hypothyroidism And The New FDA Ruling appeared first on Radio Health Journal.
